Latest News - Business of Medicine

Friday, February 15, 2019

Dermatology Drugs Market to Reach $34.5 Billion by 2023

The dermatology drugs market is expected to reach $34.5 billion by 2023, a new report suggests. Research and Markets says that, among topical corticosteroids, retinoids, biologics, calcineurin in…

Read the full story

Friday, February 15, 2019

FDA Proposes Policy for New Competitive Generic Therapies Pathway

The FDA has issued a new policy it says is intended to improve access and increase competition for drugs that lack generic competition.  The new pathway for Competitive Generic Therapies (CGTs…

Read the full story

Wednesday, February 06, 2019

Study Finds Lack of Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations

A recent study published in JAMA Dermatology was conducted to examine potential financial conflicts of interest and characterize disclosure practices among dermatology patient advocacy organizations. …

Read the full story

Friday, February 01, 2019

Vyome Secures $22M to Advance Dermatology Pipeline

Vyome Therapeutics Inc., a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, closed $22 million in financing.&nbs…

Read the full story

Thursday, January 24, 2019

Dermatologists Call for Changes to Off-label Coverage Decisions

Dermatologists report major inconsistencies in Medicare Reimbursement Policy for off-label prescriptions and are now calling for an appeal process for cases where coverage is denied. Researchers from …

Read the full story

Thursday, December 20, 2018

Modernizing Medicine Introduces New Patient Engagement Tools

Modernizing Medicine has launched enhanced patient engagement tools powered by Relatient that are designed to reduce no-shows and improve patient compliance, satisfaction, and operation…

Read the full story

Tuesday, November 20, 2018

LEO, PellePharm Form Collaboration Focused on Innovation

A new strategic development and commercialization collaboration between LEO Pharma and PellePharm is intended to address unmet medical needs across various skin diseases with no approved treatments, t…

Read the full story

Thursday, November 15, 2018

MDsave Partners with CareCredit

MDsave is partnering with CareCredit to bring easy healthcare financing to their mission of providing better cost transparency to patients. As consumers face ever increasing healthcare costs, CareCred…

Read the full story

Tuesday, October 23, 2018

Almirall, LLC is the New Name of Aqua

Almirall, LLC is the new name of Aqua Pharmaceuticals. Almirall, LLC is part of the larger Almirall, S.A. family, an internationally-recognized global dermatology pharmaceutical company, wit…

Read the full story

Monday, September 24, 2018

Nestle to Explore Strategic Options for Skin Health Division

...After further analysis and consideration, the Board has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group’s strategic…

Read the full story

Tuesday, September 04, 2018

JW Pharmaceutical Signs Global Out-licensing Agreement for Atopic Dermatitis Drug Candidate with LEO Pharma

JW Pharmaceutical and LEO Pharma A/S have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601, under which, LEO Pharma will gain the exclusive rights to …

Read the full story

Thursday, August 30, 2018

Compulink Launches Advantage SMART Practice Suite of AI Solutions

Compulink Healthcare Solutions rolled out new artificial intelligence (AI)-enabled features in a release its calling Advantage SMART Practice. Advantage uses AI technology and real-time data from the …

Read the full story

Monday, August 27, 2018

Latest on Compounding: FDA Proposes to Strike Three Bulk Drug Substances from List

The FDA has issued a Federal Register notice proposing not to include three bulk drug substances, bumetanide, nicardipine hydrochloride, and vasopressin, on the list of bulk drug substances …

Read the full story

Thursday, August 23, 2018

FDA Adds Four Tropical Diseases to Priority Review Voucher Program

The FDA announced the addition of Lassa fever, chikungunya virus disease, rabies and cryptococcal meningitis to the list of tropical diseases.

Read the full story

Thursday, August 16, 2018

"Phenomenal Gains" in Derm Device Market, Global Market Insights Predicts

Dermatology devices market, an integral vertical of medical equipment space, of late, has been providing lucrative opportunities to the investors to exploit economies of scale. The claim is very well …

Read the full story
Load More